Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review.

Fusi-Rubiano W, Blow RR, Lane M, Morjaria R, Denniston AK.

Ophthalmol Ther. 2020 Feb 7. doi: 10.1007/s40123-020-00231-3. [Epub ahead of print]

PMID:
32034688
2.

Instrument-based tests for quantifying aqueous humour protein levels in uveitis: a systematic review protocol.

McNally TW, Liu X, Beese S, Keane PA, Moore DJ, Denniston AK.

Syst Rev. 2019 Nov 26;8(1):287. doi: 10.1186/s13643-019-1206-2.

3.

Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Pouwels XGLV, Petersohn S, Carrera VH, Denniston AK, Chalker A, Raatz H, Armstrong N, Shah D, Witlox W, Worthy G, Noake C, Riemsma R, Kleijnen J, Joore MA.

Pharmacoeconomics. 2019 Nov 8. doi: 10.1007/s40273-019-00851-z. [Epub ahead of print] Review.

PMID:
31701471
4.

Optical coherence tomography (OCT) in unconscious and systemically unwell patients using a mobile OCT device: a pilot study.

Liu X, Kale AU, Capewell N, Talbot N, Ahmed S, Keane PA, Mollan S, Belli A, Blanch RJ, Veenith T, Denniston AK.

BMJ Open. 2019 Nov 7;9(11):e030882. doi: 10.1136/bmjopen-2019-030882. Erratum in: BMJ Open. 2020 Feb 4;10(2):e030882corr1.

5.

Comment on: 'Quantification of anterior chamber reaction after intravitreal injections of conbercept and ranibizumab: a pilot study'.

Minocha A, Liu X, Denniston AK, Petrushkin H, Solebo AL.

Eye (Lond). 2019 Oct 30. doi: 10.1038/s41433-019-0657-y. [Epub ahead of print] No abstract available.

PMID:
31666709
6.

Extension of the CONSORT and SPIRIT statements.

Liu X, Faes L, Calvert MJ, Denniston AK; CONSORT/SPIRIT-AI Extension Group.

Lancet. 2019 Oct 5;394(10205):1225. doi: 10.1016/S0140-6736(19)31819-7. Epub 2019 Sep 16. No abstract available.

PMID:
31537414
7.

Instrument-based Tests for Measuring Anterior Chamber Cells in Uveitis: A Systematic Review.

Liu X, Solebo AL, Faes L, Beese S, Braithwaite T, Round ME, Panthagani J, Kale AU, McNally TW, Abdulla D, Keane PA, Moore DJ, Denniston AK.

Ocul Immunol Inflamm. 2019 Aug 16:1-12. doi: 10.1080/09273948.2019.1640883. [Epub ahead of print]

PMID:
31418609
8.

Colour contrast sensitivity in eyes at high risk of neovascular age-related macular degeneration.

Calcagni A, Howells O, Eperjesi F, Bartlett H, Denniston AK, Gibson JM, Hogg CR, Matthews TD.

Eur J Ophthalmol. 2019 Aug 14:1120672119866386. doi: 10.1177/1120672119866386. [Epub ahead of print]

PMID:
31411062
9.

Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis.

Coric D, Ometto G, Montesano G, Keane PA, Balk LJ, Uitdehaag BMJ, Petzold A, Crabb DP, Denniston AK.

Eur J Neurol. 2020 Jan;27(1):144-e3. doi: 10.1111/ene.14048. Epub 2019 Aug 18.

10.

Evaluating the Impact of Uveitis on Visual Field Progression Using Large-Scale Real-World Data.

Liu X, Kelly SR, Montesano G, Bryan SR, Barry RJ, Keane PA, Denniston AK, Crabb DP.

Am J Ophthalmol. 2019 Nov;207:144-150. doi: 10.1016/j.ajo.2019.06.004. Epub 2019 Jun 26.

11.

Does access to a portable ophthalmoscope improve skill acquisition in direct ophthalmoscopy? A method comparison study in undergraduate medical education.

Gilmour-White JA, Picton A, Blaikie A, Denniston AK, Blanch R, Coleman J, Murray PI.

BMC Med Educ. 2019 Jun 13;19(1):201. doi: 10.1186/s12909-019-1644-5.

12.

Patient priorities in herpes simplex keratitis.

Liu X, Kolli S, McDonnell P, Patel A, Quinlan M, Skym K, Denniston AK, Shah P, Williams GP.

BMJ Open Ophthalmol. 2019 Apr 25;4(1):e000177. doi: 10.1136/bmjophth-2018-000177. eCollection 2019.

13.

ReLayer: a Free, Online Tool for Extracting Retinal Thickness From Cross-Platform OCT Images.

Ometto G, Moghul I, Montesano G, Hunter A, Pontikos N, Jones PR, Keane PA, Liu X, Denniston AK, Crabb DP.

Transl Vis Sci Technol. 2019 May 29;8(3):25. doi: 10.1167/tvst.8.3.25. eCollection 2019 May.

14.

Under-utilisation of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research.

Solebo AL, Barry RJ, Keane PA, Rahi JS, Denniston AK.

Orphanet J Rare Dis. 2019 Jun 6;14(1):125. doi: 10.1186/s13023-019-1108-3. Review.

15.

The Uveitis Patient Passport: A Self-Care Tool.

Bailie HN, Liu X, Bruynseels A, Denniston AK, Shah P, Sii F.

Ocul Immunol Inflamm. 2019 Mar 1:1-6. doi: 10.1080/09273948.2019.1569240. [Epub ahead of print]

PMID:
30821566
16.

Comprehensive sequencing of the myocilin gene in a selected cohort of severe primary open-angle glaucoma patients.

O'Gorman L, Cree AJ, Ward D, Griffiths HL, Sood R, Denniston AK, Self JE, Ennis S, Lotery AJ, Gibson J.

Sci Rep. 2019 Feb 28;9(1):3100. doi: 10.1038/s41598-019-38760-y.

17.

The Effectiveness of Pharmacological Agents for the Treatment of Uveitic Macular Edema (UMO): A Systematic Review.

Tallouzi MO, Moore DJ, Barry RJ, Calvert M, Mathers J, Murray PI, Denniston AK.

Ocul Immunol Inflamm. 2019;27(4):658-680. doi: 10.1080/09273948.2019.1569243. Epub 2019 Feb 27.

PMID:
30811272
18.

The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice.

Braithwaite T, Calvert M, Gray A, Pesudovs K, Denniston AK.

Patient Relat Outcome Meas. 2019 Jan 24;10:9-24. doi: 10.2147/PROM.S162802. eCollection 2019. Review.

19.

Dexamethasone implant for non-infectious uveitis: is it cost-effective?

Squires H, Bermejo I, Poku EN, Cooper K, Stevens J, Hamilton J, Wong R, Denniston AK, Pearce I, Quhill FM.

Br J Ophthalmol. 2019 Nov;103(11):1639-1644. doi: 10.1136/bjophthalmol-2018-312765. Epub 2019 Feb 11.

20.

Adalimumab for non-infectious uveitis: is it cost-effective?

Bermejo I, Squires H, Poku EN, Cooper K, Stevens JW, Hamilton J, Wong R, Pearce I, Quhill FM, Denniston AK.

Br J Ophthalmol. 2019 Nov;103(11):1633-1638. doi: 10.1136/bjophthalmol-2018-312756. Epub 2019 Feb 6.

21.

Instrument-based tests for measuring anterior chamber cells in uveitis: a systematic review protocol.

Liu X, Solebo AL, Keane PA, Moore DJ, Denniston AK.

Syst Rev. 2019 Jan 22;8(1):30. doi: 10.1186/s13643-019-0946-3.

22.

Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.

Barry RJ, Tallouzi MO, Bucknall N, Mathers JM, Murray PI, Calvert MJ, Moore DJ, Denniston AK.

Cochrane Database Syst Rev. 2018 Dec 18;12:CD012577. doi: 10.1002/14651858.CD012577.pub2.

23.

United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services.

Denniston AK, Lee AY, Lee CS, Crabb DP, Bailey C, Lip PL, Taylor P, Pikoula M, Cook E, Akerele T, Antcliff R, Brand C, Chakravarthy U, Chavan R, Dhingra N, Downey L, Eleftheriadis H, Ghanchi F, Khan R, Kumar V, Lobo A, Lotery A, Menon G, Mukherjee R, Palmer H, Patra S, Paul B, Sim DA, Talks JS, Wilkinson E, Tufail A, Egan CA; UK DR EMR Users Group.

Br J Ophthalmol. 2019 Jun;103(6):837-843. doi: 10.1136/bjophthalmol-2018-312568. Epub 2018 Sep 29.

24.

Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review.

Fusi-Rubiano W, Blow RR, Lane M, Morjaria R, Denniston AK.

Ophthalmol Ther. 2018 Dec;7(2):293-305. doi: 10.1007/s40123-018-0145-7. Epub 2018 Sep 18. Review. Erratum in: Ophthalmol Ther. 2020 Feb 7;:.

25.

mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol.

Blair J, Barry R, Murray PI, Moore DJ, Denniston AK.

Syst Rev. 2018 Jun 9;7(1):83. doi: 10.1186/s13643-018-0745-2. Review.

26.

Time to regenerate: the doctor in the age of artificial intelligence.

Liu X, Keane PA, Denniston AK.

J R Soc Med. 2018 Apr;111(4):113-116. doi: 10.1177/0141076818762648. Review. No abstract available.

PMID:
29648509
27.

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years.

Fusi-Rubiano W, Mukherjee C, Lane M, Tsaloumas MD, Glover N, Kidess A, Denniston AK, Palmer HE, Manna A, Morjaria R.

BMC Ophthalmol. 2018 Feb 27;18(1):62. doi: 10.1186/s12886-018-0726-1.

28.

Optimizing OCT acquisition parameters for assessments of vitreous haze for application in uveitis.

Montesano G, Way CM, Ometto G, Ibrahim H, Jones PR, Carmichael R, Liu X, Aslam T, Keane PA, Crabb DP, Denniston AK.

Sci Rep. 2018 Jan 26;8(1):1648. doi: 10.1038/s41598-018-20092-y.

29.

Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.

Barry RJ, Tasiopoulou A, Murray PI, Patel PJ, Sagoo MS, Denniston AK, Keane PA.

Br J Ophthalmol. 2018 Oct;102(10):1362-1366. doi: 10.1136/bjophthalmol-2017-311612. Epub 2018 Jan 6.

PMID:
29306864
30.

A retrospective cohort study of patients treated with anti-tuberculous therapy for presumed ocular tuberculosis.

Damato EM, Dawson S, Liu X, Mukherjee C, Horsburgh J, Denniston AK, Moran E, Dedicoat M, Murray PI.

J Ophthalmic Inflamm Infect. 2017 Dec 4;7(1):23. doi: 10.1186/s12348-017-0141-4.

31.

COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.

Tallouzi MO, Mathers JM, Moore DJ, Murray PI, Bucknall N, Blazeby JM, Calvert M, Denniston AK.

Trials. 2017 Dec 1;18(1):576. doi: 10.1186/s13063-017-2294-8.

32.

Birdshot Chorioretinopathy.

Cunningham ET, Levinson RD, Denniston AK, Brézin AP, Zierhut M.

Ocul Immunol Inflamm. 2017 Oct;25(5):589-593. doi: 10.1080/09273948.2017.1400800. No abstract available.

PMID:
29144845
33.

Multiple deprivation, vision loss, and ophthalmic disease in adults: global perspectives.

Lane M, Lane V, Abbott J, Braithwaite T, Shah P, Denniston AK.

Surv Ophthalmol. 2018 May - Jun;63(3):406-436. doi: 10.1016/j.survophthal.2017.10.009. Epub 2017 Nov 1. Review.

PMID:
29100897
34.

Development and validation of a questionnaire assessing the quality of life impact of Colour Blindness (CBQoL).

Barry JA, Mollan S, Burdon MA, Jenkins M, Denniston AK.

BMC Ophthalmol. 2017 Oct 2;17(1):179. doi: 10.1186/s12886-017-0579-z.

35.

Uveitis: a sight-threatening disease which can impact all systems.

Krishna U, Ajanaku D, Denniston AK, Gkika T.

Postgrad Med J. 2017 Dec;93(1106):766-773. doi: 10.1136/postgradmedj-2017-134891. Epub 2017 Sep 23. Review.

PMID:
28942431
36.

An overview of the clinical applications of optical coherence tomography angiography.

Tan ACS, Tan GS, Denniston AK, Keane PA, Ang M, Milea D, Chakravarthy U, Cheung CMG.

Eye (Lond). 2018 Feb;32(2):262-286. doi: 10.1038/eye.2017.181. Epub 2017 Sep 8. Review.

37.

An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.

McNally TW, Damato EM, Murray PI, Denniston AK, Barry RJ.

Orphanet J Rare Dis. 2017 Jul 17;12(1):130. doi: 10.1186/s13023-017-0681-6. Review.

38.

Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors.

Okafor LO, Hewins P, Murray PI, Denniston AK.

Orphanet J Rare Dis. 2017 Jul 14;12(1):128. doi: 10.1186/s13023-017-0677-2. Review.

39.

False Negative Toxoplasma Serology in an Immunocompromised Patient with PCR Positive Ocular Toxoplasmosis.

Rajput R, Denniston AK, Murray PI.

Ocul Immunol Inflamm. 2018;26(8):1200-1202. doi: 10.1080/09273948.2017.1332769. Epub 2017 Jul 12.

PMID:
28700250
40.

Biomarkers and Surrogate Endpoints in Uveitis: The Impact of Quantitative Imaging.

Denniston AK, Keane PA, Srivastava SK.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO131-BIO140. doi: 10.1167/iovs.17-21788. Review.

PMID:
28655060
41.

The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.

Lee CS, Lee AY, Baughman D, Sim D, Akelere T, Brand C, Crabb DP, Denniston AK, Downey L, Fitt A, Khan R, Mahmood S, Mandal K, Mckibbin M, Menon G, Lobo A, Kumar BV, Natha S, Varma A, Wilkinson E, Mitry D, Bailey C, Chakravarthy U, Tufail A, Egan C; UK DR EMR Users Group.

Am J Ophthalmol. 2017 Aug;180:64-71. doi: 10.1016/j.ajo.2017.05.020. Epub 2017 May 29.

42.

The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.

Denniston AK, Chakravarthy U, Zhu H, Lee AY, Crabb DP, Tufail A, Bailey C, Akerele T, Al-Husainy S, Brand C, Downey L, Fitt A, Khan R, Kumar V, Lobo A, Mahmood S, Mandal K, Mckibbin M, Menon G, Natha S, Ong JM, Tsaloumas MD, Varma A, Wilkinson E, Johnston RL, Egan CA; UK DR EMR Users Group.

Br J Ophthalmol. 2017 Dec;101(12):1673-1678. doi: 10.1136/bjophthalmol-2016-309838. Epub 2017 May 9.

PMID:
28487377
43.

"The patient is speaking": discovering the patient voice in ophthalmology.

Dean S, Mathers JM, Calvert M, Kyte DG, Conroy D, Folkard A, Southworth S, Murray PI, Denniston AK.

Br J Ophthalmol. 2017 Jun;101(6):700-708. doi: 10.1136/bjophthalmol-2016-309955. Epub 2017 Apr 28. Review.

44.

Patent foramen ovale presenting as visual loss.

Liu X, Calvert PA, Arif S, Keane PA, Denniston AK.

JRSM Open. 2016 Dec 1;8(1):2054270416669302. doi: 10.1177/2054270416669302. eCollection 2016 Jan.

45.

The Ocular Glymphatic System and Idiopathic Intracranial Hypertension: Author Response to "Hypodense Holes and the Ocular Glymphatic System".

Denniston AK, Keane PA, Aojula A, Sinclair AJ, Mollan SP.

Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1134-1136. doi: 10.1167/iovs.17-21479. No abstract available.

PMID:
28196227
46.

A Comprehensive Review of mTOR-Inhibiting Pharmacotherapy for the Treatment of Non-Infectious Uveitis.

Blair J, Barry R, Moore DJ, Denniston AK.

Curr Pharm Des. 2017;23(20):3005-3014. doi: 10.2174/1381612823666170111125550. Review.

PMID:
28078989
47.

Cataract surgery in uveitis: a multicentre database study.

Chu CJ, Dick AD, Johnston RL, Yang YC, Denniston AK; UK Pseudophakic Macular Edema Study Group.

Br J Ophthalmol. 2017 Aug;101(8):1132-1137. doi: 10.1136/bjophthalmol-2016-309047. Epub 2017 Jan 2.

PMID:
28043984
48.

"Black Holes" and the Ocular Glymphatic System: Author Response to "The Glymphatic System: A New Player in Ocular Diseases?"

Denniston AK, Keane PA.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5428. doi: 10.1167/iovs.16-20479. No abstract available.

PMID:
27768787
49.

Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid.

Williams GP, Nightingale P, Southworth S, Denniston AK, Tomlins PJ, Turner S, Hamburger J, Bowman SJ, Curnow SJ, Rauz S.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5457-5469. doi: 10.1167/iovs.16-19247.

50.

Punctate inner choroidopathy: A review.

Ahnood D, Madhusudhan S, Tsaloumas MD, Waheed NK, Keane PA, Denniston AK.

Surv Ophthalmol. 2017 Mar - Apr;62(2):113-126. doi: 10.1016/j.survophthal.2016.10.003. Epub 2016 Oct 15. Review.

PMID:
27751823

Supplemental Content

Loading ...
Support Center